Brief: Klaria Announces Positive Results In Pre-Clinical Study With Transmucosal Oral Film Of Ketamine

Klaria Pharma Holding AB (publ)

24/09/2019 07:36

Sept 24 (Reuters) - Klaria Pharma Holding AB (publ)
 KLAR.ST :
    * KLARIA ANNOUNCES POSITIVE RESULTS IN A PRE-CLINICAL,
PROOF-OF-CONCEPT STUDY WITH TRANSMUCOSAL ORAL FILM OF KETAMINE
AND FILES PATENT TO PROTECT THE INNOVATIVE FORMULATION
    * RESULTS OF STUDY WERE HIGHLY SUCCESSFUL WITH PEAK KETAMINE
LEVELS IN BLOOD APPEARING QUICKLY, WITHIN 3 TO 10 MINUTES
    * EXTENT OF ABSORPTION OF KETAMINE WAS ALSO ENCOURAGING AND
FAR
EXCEEDED ABSORPTION FROM NASAL SPRAYS AS REPORTED IN LITERATURE
    * WITH THIS DATA, PROGRAM IS NOW READY FOR CLINICAL
DEVELOPMENT
    * KLARIA ANNOUNCES THAT IT HAS FILED FOR PATENT PROTECTION
OF NEW
FORMULATION
    * PATENT APPLICATION IS APPLICABLE GLOBALLY

Source text for Eikon:  ID:nWkr5MD1RL 
Further company coverage:  KLAR.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))